drugset
drugset / Trial / NCT06690450

Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) Patients

NCT06690450 ↗

Phase 4 Completed 400 enrolled American Regent, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The Objective of this study is to assess the Safety and Tolerability of 200 mg and 100 mg of Venofer Administered to Hemodialysis(HD) Patients.

Timeline

Start
2001-08
Primary completion
2002-01
Completion
2002-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron sucrose Unknown 100 mg Intravenous
Subject Iron sucrose Unknown 200 mg Intravenous

Indications

No indication recorded.